These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Correlation between delay in initiating clozapine and symptomatic improvement. Yada Y; Yoshimura B; Kishi Y Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084 [No Abstract] [Full Text] [Related]
6. Differential effectiveness of clozapine for patients nonresponsive to or intolerant of first generation antipsychotic medications. Jackson CT; Covell NH; Essock SM Schizophr Bull; 2004; 30(2):219-27. PubMed ID: 15279041 [TBL] [Abstract][Full Text] [Related]
7. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
8. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771 [TBL] [Abstract][Full Text] [Related]
9. Elevated Clozapine Level Following Acute Infection in a Patient with Schizophrenia: a Case Report. Poon JYK; Tang DYY; Siu BWM; Lui SH East Asian Arch Psychiatry; 2020 Dec; 30(4):120-121. PubMed ID: 33349619 [TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
11. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy. Khodayari-Rostamabad A; Hasey GM; Maccrimmon DJ; Reilly JP; de Bruin H Clin Neurophysiol; 2010 Dec; 121(12):1998-2006. PubMed ID: 21035741 [TBL] [Abstract][Full Text] [Related]
12. Clozapine with amisulpride for refractory schizophrenia. Agelink MW; Kavuk I; Ak I Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665 [No Abstract] [Full Text] [Related]
16. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043 [TBL] [Abstract][Full Text] [Related]
17. [Clozapine--an atypical neuroleptic with a unique clinical profile]. Lindström L; Lundberg T Lakartidningen; 1992 Jun; 89(26-27):2368-72. PubMed ID: 1354777 [No Abstract] [Full Text] [Related]
18. [Clozapine and treatment of negative symptoms]. Lançon C; Farisse J; Llorca PM Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403 [TBL] [Abstract][Full Text] [Related]
19. Duration of a clozapine trial in neuroleptic-resistant schizophrenia. Meltzer HY Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591 [No Abstract] [Full Text] [Related]
20. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]